Safety, Tolerability, Pharmacokinetics and Quantitative Electroencephalography Assessment of ACD856, a Novel Positive Allosteric Modulator of Trk-Receptors Following Multiple Doses in Healthy Subjects.

Önnestam, K; Nilsson, B; Rother, M; Rein-Hedin, E; Bylund, J; Anderer, P; Kemethofer, M; Halldin, M M; Sandin, J; Segerdahl, M

Önnestam, K; Nilsson, B; Rother, M; Rein-Hedin, E; Bylund, J; Anderer, P; Kemethofer, M; Halldin, M M; Sandin, J; Segerdahl, M.

Affiliation

Önnestam K; Märta Segerdahl, AlzeCure Pharma AB, Hälsovägen 7, SE-141 57 Huddinge, Sweden, Phone: +46 736 808 898, E-mail: marta.segerdahl@alzecurepharma.com.

J Prev Alzheimers Dis ; 10(4): 778-789, 2023.

Article in En | MEDLINE | ID: mdl-37874100

Subject(s)

Electroencephalography; Humans; Male; Female; Healthy Volunteers; Prospective Studies; Administration, Oral; Double-Blind Method

Key words

ACD856; Alzheimer's Disease; Trk; multiple ascending doses; neurotrophin

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Electroencephalography Limits: Female / Humans / Male Language: En Journal: J Prev Alzheimers Dis Year: 2023 Type: Article

Fulltext

XML

PubMed Links

Search on Google